Milligan Michael Lee sold NMRA
February 17, 2026 · Form 4 insider transaction
Milligan Michael Lee sold 1,436 shares of Neumora Therapeutics, Inc. at $3.56 per share, a transaction worth $5.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,436
Price
$3.56
Total value
$5.1K
InsiderMilligan Michael Lee
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 17, 2026
Filing dateFebruary 19, 2026
Shares owned after21,034
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on August 30, 2024, which provides for the automatic sale of shares of common stock that would otherwise be issuable on each vesting date of a covered restricted stock unit in an amount necessary to satisfy the applicable withholding obligation.